David Masao Ota
Professor of Surgery
Current Appointments & Affiliations
- Professor of Surgery, Surgical Oncology, Surgery 2006
- Member in the Duke Clinical Research Institute, Duke Clinical Research Institute, Institutes and Centers 2005
Contact Information
- 7023 North Pavilion, 2400 Pratt Street, Durham, NC 27705
- Box 3850 Med Ctr, Durham, NC 27710
-
david.ota@duke.edu
(919) 668-5987
- Background
-
Education, Training, & Certifications
- M.D., The University of Chicago 1973
-
Previous Appointments & Affiliations
- Consulting Professor of Surgery, Surgery, Clinical Science Departments 2005 - 2006
- Research
-
Selected Grants
- Support for Specimen Banking in ACOSOG GY 6 awarded by National Institutes of Health 2005 - 2012
- ACOSOG Competing Renewal awarded by National Institutes of Health 2008 - 2011
- ACOSOG Supplemental Z1072 awarded by National Institutes of Health 2008 - 2010
- ACOSOG Grant Year 11 awarded by National Institutes of Health 1998 - 2007
- Publications & Artistic Works
-
Selected Publications
-
Academic Articles
-
Lesurf, R., O. L. Griffith, M. Griffith, J. Hundal, L. Trani, M. A. Watson, R. Aft, et al. “Genomic characterization of HER2-positive breast cancer and response to neoadjuvant trastuzumab and chemotherapy-results from the ACOSOG Z1041 (Alliance) trial.” Ann Oncol 28, no. 5 (May 1, 2017): 1070–77. https://doi.org/10.1093/annonc/mdx048.Full Text Link to Item
-
Ellis, Matthew J., Vera J. Suman, Jeremy Hoog, Rodrigo Goncalves, Souzan Sanati, Chad J. Creighton, Katherine DeSchryver, et al. “Ki67 Proliferation Index as a Tool for Chemotherapy Decisions During and After Neoadjuvant Aromatase Inhibitor Treatment of Breast Cancer: Results From the American College of Surgeons Oncology Group Z1031 Trial (Alliance).” J Clin Oncol 35, no. 10 (April 1, 2017): 1061–69. https://doi.org/10.1200/JCO.2016.69.4406.Full Text Link to Item
-
McCarter, Martin D., Cristina R. Antonescu, Karla V. Ballman, Robert G. Maki, Peter W. T. Pisters, George D. Demetri, Charles D. Blanke, et al. “Microscopically positive margins for primary gastrointestinal stromal tumors: analysis of risk factors and tumor recurrence.” J Am Coll Surg 215, no. 1 (July 2012): 53–59. https://doi.org/10.1016/j.jamcollsurg.2012.05.008.Full Text Link to Item
-
McDonald, Sandra A., Elaine R. Mardis, David Ota, Mark A. Watson, John D. Pfeifer, and Jonathan M. Green. “Comprehensive genomic studies: emerging regulatory, strategic, and quality assurance challenges for biorepositories.” Am J Clin Pathol 138, no. 1 (July 2012): 31–41. https://doi.org/10.1309/AJCPXBA69LNSCVMH.Full Text Link to Item
-
Ellis, Matthew J., Li Ding, Dong Shen, Jingqin Luo, Vera J. Suman, John W. Wallis, Brian A. Van Tine, et al. “Whole-genome analysis informs breast cancer response to aromatase inhibition.” Nature 486, no. 7403 (June 10, 2012): 353–60. https://doi.org/10.1038/nature11143.Full Text Link to Item
-
Diehl, Kathleen M., Erin M. Green, Armin Weinberg, Wayne A. Frederick, Dennis R. Holmes, Bettye Green, Arden Morris, et al. “Features associated with successful recruitment of diverse patients onto cancer clinical trials: report from the American College of Surgeons Oncology Group.” Ann Surg Oncol 18, no. 13 (December 2011): 3544–50. https://doi.org/10.1245/s10434-011-1818-9.Full Text Link to Item
-
Ota, David M., A Marilyn Leitch, and Gary Unzeitig. “American College of Surgeons Oncology Group and the community surgeon.” Surg Oncol Clin N Am 20, no. 3 (July 2011): 439–vii. https://doi.org/10.1016/j.soc.2011.01.006.Full Text Link to Item
-
You, Y Nancy, Lisa Jacobs, Elizabeth Martinez, and David M. Ota. “The audit process and how to ensure a successful audit.” Cancer Treat Res 132 (2007): 179–97. https://doi.org/10.1007/978-0-387-33225-3_9.Full Text Link to Item
-
You, Y Nancy, Lisa Jacobs, Elizabeth D. Martinez, Susan C. Budinger, E Jean Wittlief, Shelley K. Myles, David M. Ota, and David M. American College of Surgeons Oncology Group. “Improved surgeon performance in clinical trials: an analysis of quality assurance audits from the American College of Surgeons Oncology Group.” J Am Coll Surg 203, no. 3 (September 2006): 269–76. https://doi.org/10.1016/j.jamcollsurg.2006.05.298.Full Text Link to Item
-
You, Y Nancy, Kelly K. Hunt, Mitchell C. Posner, Joe B. Putnam, Heidi Nelson, David M. Ota, and Peter W. T. Pisters. “Operative trials: the opportunity beckons-an update on the American College of Surgeons Oncology Group.” Surgery 139, no. 4 (April 2006): 455–59. https://doi.org/10.1016/j.surg.2005.08.008.Full Text Link to Item
-
Newman, Lisa A., Cheryl T. Lee, Lina Patel Parekh, Andrew K. Stewart, Charles R. Thomas, Robert A. Beltran, Anthony Lucci, et al. “Use of the National Cancer Data Base to develop clinical trials accrual targets that are appropriate for minority ethnicity patients: a report from the American College of Surgeons Oncology Group (ACOSOG) Special Population Committee.” Cancer 106, no. 1 (January 1, 2006): 188–95. https://doi.org/10.1002/cncr.21592.Full Text Link to Item
-
Redlich, Philip N., Anna C. Purdy, Vinod B. Shidham, Hyun J. Yun, Alonzo Walker, and David Ota. “Feasibility of breast duct lavage performed by a physician extender.” Surgery 136, no. 5 (November 2004): 1077–80. https://doi.org/10.1016/j.surg.2004.08.004.Full Text Link to Item
-
Lin, Kevin M., Tarak H. Patel, Adrian Ray, Matthew Ota, Lisa Jacobs, Boris Kuvshinoff, Mathew Chung, Michael Watson, and David M. Ota. “Intradermal radioisotope is superior to peritumoral blue dye or radioisotope in identifying breast cancer sentinel nodes.” J Am Coll Surg 199, no. 4 (October 2004): 561–66. https://doi.org/10.1016/j.jamcollsurg.2004.06.018.Full Text Link to Item
-
Clinical Outcomes of Surgical Therapy Study Group, David, Heidi Nelson, Daniel J. Sargent, H Sam Wieand, James Fleshman, Mehran Anvari, Steven J. Stryker, et al. “A comparison of laparoscopically assisted and open colectomy for colon cancer.” N Engl J Med 350, no. 20 (May 13, 2004): 2050–59. https://doi.org/10.1056/NEJMoa032651.Full Text Link to Item
-
Annie Yu, Hwei-Ju, Kevin M. Lin, David M. Ota, and Henry T. Lynch. “Hereditary nonpolyposis colorectal cancer: preventive management.” Cancer Treat Rev 29, no. 6 (December 2003): 461–70. https://doi.org/10.1016/s0305-7372(03)00084-7.Full Text Link to Item
-
Heidemann, Jan, Hitoshi Ogawa, Michael B. Dwinell, Parvaneh Rafiee, Christian Maaser, Henning R. Gockel, Mary F. Otterson, et al. “Angiogenic effects of interleukin 8 (CXCL8) in human intestinal microvascular endothelial cells are mediated by CXCR2.” J Biol Chem 278, no. 10 (March 7, 2003): 8508–15. https://doi.org/10.1074/jbc.M208231200.Full Text Link to Item
-
Kuvshinoff, Boris W., and David M. Ota. “Radiofrequency ablation of liver tumors: influence of technique and tumor size.” Surgery 132, no. 4 (October 2002): 605–11. https://doi.org/10.1067/msy.2002.127545.Full Text Link to Item
-
Ota, David M., Lisa Jacobs, and Boris Kuvshinoff. “Rectal cancer: the sphincter-sparing approach.” Surg Clin North Am 82, no. 5 (October 2002): 983–93. https://doi.org/10.1016/s0039-6109(02)00048-8.Full Text Link to Item
-
Lin, Kevin M., Fausto Rodriguez, and David M. Ota. “The sentinel node in colorectal carcinoma. Mapping technique, pathologic assessment, and clinical relevance.” Oncology (Williston Park) 16, no. 5 (May 2002): 567–80.Link to Item
-
Nelson, H., N. Petrelli, A. Carlin, J. Couture, J. Fleshman, J. Guillem, B. Miedema, D. Ota, D. Sargent, and D. National Cancer Institute Expert Panel. “Guidelines 2000 for colon and rectal cancer surgery.” J Natl Cancer Inst 93, no. 8 (April 18, 2001): 583–96. https://doi.org/10.1093/jnci/93.8.583.Full Text Link to Item
-
Kuvshinoff, B., I. Maghfoor, B. Miedema, M. Bryer, S. Westgate, J. Wilkes, and D. Ota. “Distal margin requirements after preoperative chemoradiotherapy for distal rectal carcinomas: are < or = 1 cm distal margins sufficient?” Ann Surg Oncol 8, no. 2 (March 2001): 163–69. https://doi.org/10.1007/s10434-001-0163-9.Full Text Link to Item
-
Ota, D. M., and K. Lin. “Lymphatic mapping and sentinel node identification for colorectal cancer.” Swiss Surg 7, no. 6 (2001): 252–55. https://doi.org/10.1024/1023-9332.7.6.252.Full Text Link to Item
-
Lin, K. M., and D. M. Ota. “Laparoscopic colectomy for cancer: an oncologic feasible option.” Surg Oncol 9, no. 3 (November 2000): 127–34. https://doi.org/10.1016/s0960-7404(01)00002-0.Full Text Link to Item
-
John, M. J., G. S. Merrick, L. R. Coia, B. D. Minsky, J. L. Bader, N. A. Janjan, D. Raben, et al. “Anal cancer. American College of Radiology. ACR Appropriateness Criteria.” Radiology 215 Suppl (June 2000): 1501–11.Link to Item
-
Rich, T. A., D. Ota, S. A. Rosenthal, B. D. Minsky, J. L. Bader, L. R. Coia, N. A. Janjan, et al. “Management of resectable rectal cancer. American College of Radiology. ACR Appropriateness Criteria.” Radiology 215 Suppl (June 2000): 1473–80.Link to Item
-
Saltz, L., D. Raben, B. D. Minsky, J. L. Bader, L. R. Coia, N. A. Janjan, M. J. John, et al. “Rectal cancer: presentation with metastatic and locally advanced disease. American College of Radiology. ACR Appropriateness Criteria.” Radiology 215 Suppl (June 2000): 1491–99.Link to Item
-
Tepper, J. E., J. L. Bader, N. A. Janjan, B. D. Minsky, L. R. Coia, M. J. John, G. S. Merrick, et al. “Locally unresectable rectal cancer. American College of Radiology. ACR Appropriateness Criteria.” Radiology 215 Suppl (June 2000): 1481–90.Link to Item
-
Ota, D. M. “Treatment of primary colon cancer with peritoneal carcinomatosis: Comparison of concomitant vs. delayed management - Invited editorial.” Diseases of the Colon & Rectum 43, no. 10 (2000): 1347–1347. https://doi.org/10.1007/BF02236628.Full Text Link to Item
-
Ajani, J. A., P. F. Mansfield, P. M. Lynch, P. W. Pisters, B. Feig, P. Dumas, D. B. Evans, et al. “Enhanced staging and all chemotherapy preoperatively in patients with potentially resectable gastric carcinoma.” J Clin Oncol 17, no. 8 (August 1999): 2403–11. https://doi.org/10.1200/JCO.1999.17.8.2403.Full Text Link to Item
-
Bold, Richard J., David M. Ota, Jaffer A. Ajani, and Paul F. Mansfield. “Peritoneal and serum tumor markers predict recurrence and survival of patients with resectable gastric cancer.” Gastric Cancer 2, no. 1 (May 1999): 1–7. https://doi.org/10.1007/s101200050013.Full Text Link to Item
-
Bouvet, M., P. F. Mansfield, J. M. Skibber, S. A. Curley, L. M. Ellis, G. G. Giacco, A. R. Madary, D. M. Ota, and B. W. Feig. “Clinical, pathologic, and economic parameters of laparoscopic colon resection for cancer.” Am J Surg 176, no. 6 (December 1998): 554–58. https://doi.org/10.1016/s0002-9610(98)00261-x.Full Text Link to Item
-
Lieber, K. A., S. B. Standiford, B. W. Kuvshinoff, and D. M. Ota. “Surgical management of aberrant sentinel lymph node drainage in cutaneous melanoma.” Surgery 124, no. 4 (October 1998): 757–61. https://doi.org/10.1067/msy.1998.90943.Full Text Link to Item
-
Ota, D. M. “Colon cancer.” Cancer Treat Res 90 (1997): 347–56. https://doi.org/10.1007/978-1-4615-6165-1_18.Full Text Link to Item
-
Ota, D. M. “Laparoscopic resection for colon cancer: a favorable view.” Important Adv Oncol, 1996, 227–29.Link to Item
-
Ota, D. M. “Laparoscopic colon resection for cancer--a favorable view.” Adv Surg 29 (1996): 141–53.Link to Item
-
Skibber, J. M., D. A. Swanson, F. C. Ames, D. M. Ota, and R. E. Pollock. “Complications of intestinal anastomosis in patients with right colectomy and ileal conduit: The M. D. Anderson Experience.” Journal of Pelvic Surgery 2, no. 5 (January 1, 1996): 234–38.
-
Ota, D. M. “Laparoscopic colon resection for cancer.” Surg Endosc 9, no. 12 (December 1995): 1318–22.Link to Item
-
Rich, T. A., J. M. Skibber, J. A. Ajani, D. J. Buchholz, K. R. Cleary, R. A. Dubrow, B. Levin, P. M. Lynch, S. H. Meterissian, and L. D. Roubein. “Preoperative infusional chemoradiation therapy for stage T3 rectal cancer.” Int J Radiat Oncol Biol Phys 32, no. 4 (July 15, 1995): 1025–29. https://doi.org/10.1016/0360-3016(95)00020-y.Full Text Link to Item
-
Weinstein, G. D., T. A. Rich, C. R. Shumate, J. M. Skibber, K. R. Cleary, J. A. Ajani, and D. M. Ota. “Preoperative infusional chemoradiation and surgery with or without an electron beam intraoperative boost for advanced primary rectal cancer.” Int J Radiat Oncol Biol Phys 32, no. 1 (April 30, 1995): 197–204. https://doi.org/10.1016/0360-3016(94)00481-y.Full Text Link to Item
-
Ota, D., B. Loftin, T. Saito, R. Lea, and J. Keller. “Virtual reality in surgical education.” Comput Biol Med 25, no. 2 (March 1995): 127–37. https://doi.org/10.1016/0010-4825(94)00009-f.Full Text Link to Item
-
Kim, Y. H., J. A. Ajani, D. M. Ota, P. Lynch, and J. A. Roth. “Value of serial carcinoembryonic antigen levels in patients with resectable adenocarcinoma of the esophagus and stomach.” Cancer 75, no. 2 (January 15, 1995): 451–56. https://doi.org/10.1002/1097-0142(19950115)75:2<451::aid-cncr2820750207>3.0.co;2-u.Full Text Link to Item
-
Ajani, J. A., P. F. Mansfield, and D. M. Ota. “Potentially resectable gastric carcinoma: current approaches to staging and preoperative therapy.” World J Surg 19, no. 2 (1995): 216–20. https://doi.org/10.1007/BF00308629.Full Text Link to Item
-
Mansfield, P. F., D. C. Hohn, B. D. Fornage, M. A. Gregurich, and D. M. Ota. “Complications and failures of subclavian-vein catheterization.” N Engl J Med 331, no. 26 (December 29, 1994): 1735–38. https://doi.org/10.1056/NEJM199412293312602.Full Text Link to Item
-
Feig, B. W., D. H. Berger, T. B. Dougherty, J. F. Dupuis, B. Hsi, R. C. Hickey, and D. M. Ota. “Pharmacologic intervention can reestablish baseline hemodynamic parameters during laparoscopy.” Surgery 116, no. 4 (October 1994): 733–39.Link to Item
-
Elftmann, T. D., H. Nelson, D. M. Ota, J. H. Pemberton, and R. W. Beart. “Laparoscopic-assisted segmental colectomy: surgical techniques.” Mayo Clin Proc 69, no. 9 (September 1994): 825–33. https://doi.org/10.1016/s0025-6196(12)61783-2.Full Text Link to Item
-
Staley, C. A., M. Miller, T. J. King, M. Clem, and D. M. Ota. “Laparoscopic intracorporeal harvest of jejunal tissue for autologous transplantation.” Surg Laparosc Endosc 4, no. 3 (June 1994): 192–95.Link to Item
-
Fuhrman, G. M., and D. M. Ota. “Laparoscopic intestinal stomas.” Dis Colon Rectum 37, no. 5 (May 1994): 444–49. https://doi.org/10.1007/BF02076189.Full Text Link to Item
-
Meterissian, S., J. Skibber, T. Rich, L. Roubein, J. Ajani, K. Cleary, and D. M. Ota. “Patterns of residual disease after preoperative chemoradiation in ultrasound T3 rectal carcinoma.” Ann Surg Oncol 1, no. 2 (March 1994): 111–16. https://doi.org/10.1007/BF02303553.Full Text Link to Item
-
Mak, A. C., T. A. Rich, T. E. Schultheiss, B. Kavanagh, D. M. Ota, and M. M. Romsdahl. “Late complications of postoperative radiation therapy for cancer of the rectum and rectosigmoid.” Int J Radiat Oncol Biol Phys 28, no. 3 (February 1, 1994): 597–603. https://doi.org/10.1016/0360-3016(94)90184-8.Full Text Link to Item
-
Nakamori, S., D. M. Ota, K. R. Cleary, K. Shirotani, and T. Irimura. “MUC1 mucin expression as a marker of progression and metastasis of human colorectal carcinoma.” Gastroenterology 106, no. 2 (February 1994): 353–61. https://doi.org/10.1016/0016-5085(94)90592-4.Full Text Link to Item
-
Irimura, T., Y. Izumi, Y. Kawamura, S. Nakamori, I. J. Fidler, K. R. Cleary, and D. M. Ota. “Carbohydrate-mediated cell adhesion as a determinant of colorectal cancer metastasis.” Cancer Bulletin 46, no. 4 (January 1, 1994): 336–43.
-
Ota, D. M. “Laparoscopic Management of Colon Cancer.” Surgical Innovation 1, no. 1 (January 1, 1994): 18–25. https://doi.org/10.1177/155335069400100105.Full Text
-
Ota, D. M., H. Nelson, and J. C. Weeks. “Controversies regarding laparoscopic colectomy for malignant diseases.” Curr Opin Gen Surg, 1994, 208–13.Link to Item
-
Ajani, J. A., R. J. Mayer, D. M. Ota, G. D. Steele, D. Evans, M. Roh, D. J. Sugarbaker, P. Dumas, C. Gray, and D. A. Vena. “Preoperative and postoperative combination chemotherapy for potentially resectable gastric carcinoma.” J Natl Cancer Inst 85, no. 22 (November 17, 1993): 1839–44. https://doi.org/10.1093/jnci/85.22.1839.Full Text Link to Item
-
Irimura, T., S. Nakamori, Y. Matsushita, Y. Taniuchi, N. Todoroki, T. Tsuji, Y. Izumi, Y. Kawamura, S. D. Hoff, and K. R. Cleary. “Colorectal cancer metastasis determined by carbohydrate-mediated cell adhesion: role of sialyl-LeX antigens.” Semin Cancer Biol 4, no. 5 (October 1993): 319–24.Link to Item
-
Grossie, V. B., J. Yick, M. Alpeter, T. C. Welbourne, and D. M. Ota. “Glutamine stability in biological tissues evaluated by fluorometric analysis.” Clin Chem 39, no. 6 (June 1993): 1059–63.Link to Item
-
Rich, T. A., J. A. Ajani, W. H. Morrison, D. Ota, and B. Levin. “Chemoradiation therapy for anal cancer: radiation plus continuous infusion of 5-fluorouracil with or without cisplatin.” Radiother Oncol 27, no. 3 (June 1993): 209–15. https://doi.org/10.1016/0167-8140(93)90076-k.Full Text Link to Item
-
Shumate, C. R., T. A. Rich, J. M. Skibber, J. A. Ajani, and D. M. Ota. “Preoperative chemotherapy and radiation therapy for locally advanced primary and recurrent rectal carcinoma. A report of surgical morbidity.” Cancer 71, no. 11 (June 1, 1993): 3690–96. https://doi.org/10.1002/1097-0142(19930601)71:11<3690::aid-cncr2820711136>3.0.co;2-h.Full Text Link to Item
-
Rich, T. A., N. H. A. Terry, M. Meistrich, K. Cleary, and D. Ota. “Pathologic, anatomic, and biologic factors correlated with local recurrence of colorectal cancer.” Seminars in Radiation Oncology 3, no. 1 (January 1, 1993): 13–19. https://doi.org/10.1016/S1053-4296(05)80073-6.Full Text
-
Grossie, V. B., K. Nishioka, J. A. Ajani, and D. M. Ota. “Substituting ornithine for arginine in total parenteral nutrition eliminates enhanced tumor growth.” J Surg Oncol 50, no. 3 (July 1992): 161–67. https://doi.org/10.1002/jso.2930500307.Full Text Link to Item
-
Ellis, L. M., D. B. Evans, D. Martin, and D. M. Ota. “Laparoscopic feeding jejunostomy tube in oncology patients.” Surg Oncol 1, no. 3 (June 1992): 245–49. https://doi.org/10.1016/0960-7404(92)90071-r.Full Text Link to Item
-
Lippman, S. M., D. R. Parkinson, L. M. Itri, R. S. Weber, S. P. Schantz, D. M. Ota, M. A. Schusterman, I. H. Krakoff, J. U. Gutterman, and W. K. Hong. “13-cis-retinoic acid and interferon alpha-2a: effective combination therapy for advanced squamous cell carcinoma of the skin.” J Natl Cancer Inst 84, no. 4 (February 19, 1992): 235–41. https://doi.org/10.1093/jnci/84.4.235.Full Text Link to Item
-
Ellis, L. M., and D. M. Ota. “Nutritional support of the critically ill cancer patient.” Cancer Bulletin 44, no. 3 (January 1, 1992): 234–43.
-
Ota, D. M., P. F. Mansfield, and J. A. Ajani. “Operative and adjuvant treatment strategies for gastric carcinoma.” Cancer Bulletin 44, no. 4 (January 1, 1992): 286–91.
-
Simmons, J. R., A. U. Buzdar, D. M. Ota, K. Marts, and G. N. Hortobagyi. “Complications associated with indwelling catheters.” Med Pediatr Oncol 20, no. 1 (1992): 22–25. https://doi.org/10.1002/mpo.2950200105.Full Text Link to Item
-
Grossie, V. B., D. M. Ota, J. A. Ajani, and K. Nishioka. “Amelioration of thrombocytopenia with concomitant ornithine in sarcoma-bearing rats receiving high dose difluoromethylornithine.” Invest New Drugs 9, no. 4 (November 1991): 321–26. https://doi.org/10.1007/BF00183572.Full Text Link to Item
-
McCready, D., R. Broadwater, M. Ross, R. Pollock, D. Ota, and C. Balch. “A case-control comparison of durability and cost between implanted reservoir and percutaneous catheters in cancer patients.” J Surg Res 51, no. 5 (November 1991): 377–81. https://doi.org/10.1016/0022-4804(91)90137-b.Full Text Link to Item
-
Irimura, T., D. M. Wynn, L. G. Hager, K. R. Cleary, and D. M. Ota. “Human colonic sulfomucin identified by a specific monoclonal antibody.” Cancer Res 51, no. 20 (October 15, 1991): 5728–35.Link to Item
-
Ajani, J. A., D. M. Ota, J. M. Jessup, F. C. Ames, C. McBride, A. Boddie, B. Levin, D. E. Jackson, M. Roh, and D. Hohn. “Resectable gastric carcinoma. An evaluation of preoperative and postoperative chemotherapy.” Cancer 68, no. 7 (October 1, 1991): 1501–6. https://doi.org/10.1002/1097-0142(19911001)68:7<1501::aid-cncr2820680706>3.0.co;2-l.Full Text Link to Item
-
Robey-Cafferty, S. S., J. A. Ajani, D. M. Ota, J. A. Roth, and J. M. Bruner. “Histologic observations and P-glycoprotein expression in gastric and esophageal adenocarcinomas treated with preoperative chemotherapy.” Arch Pathol Lab Med 115, no. 8 (August 1991): 807–12.Link to Item
-
Lotan, R., Y. Matsushita, D. Ohannesian, D. Carralero, D. M. Ota, K. R. Cleary, G. L. Nicolson, and T. Irimura. “Lactose-binding lectin expression in human colorectal carcinomas. Relation to tumor progression.” Carbohydr Res 213 (June 25, 1991): 47–57. https://doi.org/10.1016/s0008-6215(00)90597-4.Full Text Link to Item
-
Nishioka, K., V. B. Grossie, T. H. Chang, J. A. Ajani, and D. M. Ota. “Colorectal ornithine decarboxylase activity in human mucosa and tumors: elevation of enzymatic activity in distal mucosa.” J Surg Oncol 47, no. 2 (June 1991): 117–20. https://doi.org/10.1002/jso.2930470211.Full Text Link to Item
-
Irimura, T., Y. Matsushita, S. D. Hoff, T. Yamori, S. Nakamori, M. L. Frazier, G. G. Giacco, K. R. Cleary, and D. M. Ota. “Ectopic expression of mucins in colorectal cancer metastasis.” Semin Cancer Biol 2, no. 2 (April 1991): 129–39.Link to Item
-
Irimura, T., Y. Matsushita, R. C. Sutton, D. Carralero, D. W. Ohannesian, K. R. Cleary, D. M. Ota, G. L. Nicolson, and R. Lotan. “Increased content of an endogenous lactose-binding lectin in human colorectal carcinoma progressed to metastatic stages.” Cancer Res 51, no. 1 (January 1, 1991): 387–93.Link to Item
-
Matsushita, Y., S. D. Hoff, E. D. Nudelman, M. Otaka, S. Hakomori, D. M. Ota, K. R. Cleary, and T. Irimura. “Metastatic behavior and cell surface properties of HT-29 human colon carcinoma variant cells selected for their differential expression of sialyl-dimeric Le(x)-antigen.” Clin Exp Metastasis 9, no. 3 (1991): 283–99. https://doi.org/10.1007/BF01753731.Full Text Link to Item
-
Broadwater, J. R., M. A. Henderson, J. L. Bell, M. J. Edwards, G. J. Smith, D. R. McCready, R. S. Swanson, M. E. Hardy, R. R. Shenk, and M. Lawson. “Outpatient percutaneous central venous access in cancer patients.” Am J Surg 160, no. 6 (December 1990): 676–80. https://doi.org/10.1016/s0002-9610(05)80773-1.Full Text Link to Item
-
Matsushita, Y., K. R. Cleary, D. M. Ota, S. D. Hoff, and T. Irimura. “Sialyl-dimeric Lewis-X antigen expressed on mucin-like glycoproteins in colorectal cancer metastases.” Lab Invest 63, no. 6 (December 1990): 780–91.Link to Item
-
Irimura, T., A. M. McIsaac, D. A. Carlson, M. Yagita, E. A. Grimm, D. G. Menter, D. M. Ota, and K. R. Clary. “Soluble factor in normal tissues that stimulates high-molecular-weight sialoglycoprotein production by human colon carcinoma cells.” Cancer Res 50, no. 11 (June 1, 1990): 3331–38.Link to Item
-
Hoff, S. D., T. Irimura, Y. Matsushita, D. M. Ota, K. R. Cleary, and S. Hakomori. “Metastatic potential of colon carcinoma. Expression of ABO/Lewis-related antigens.” Arch Surg 125, no. 2 (February 1990): 206–9. https://doi.org/10.1001/archsurg.1990.01410140084013.Full Text Link to Item
-
Ajani, J. A., D. M. Ota, V. B. Grossie, J. L. Abbruzzese, J. S. Faintuch, Y. Z. Patt, D. E. Jackson, B. Levin, and K. Nishioka. “Evaluation of continuous-infusion alpha-difluoromethylornithine therapy for colorectal carcinoma.” Cancer Chemother Pharmacol 26, no. 3 (1990): 223–26. https://doi.org/10.1007/BF02897204.Full Text Link to Item
-
Hoff, S. D., Y. Matsushita, D. M. Ota, K. R. Cleary, T. Yamori, S. Hakomori, and T. Irimura. “Increased expression of sialyl-dimeric LeX antigen in liver metastases of human colorectal carcinoma.” Cancer Res 49, no. 24 Pt 1 (December 15, 1989): 6883–88.Link to Item
-
Ajani, J. A., D. M. Ota, V. B. Grossie, B. Levin, and K. Nishioka. “Alterations in polyamine metabolism during continuous intravenous infusion of alpha-difluoromethylornithine showing correlation of thrombocytopenia with alpha-difluoromethylornithine plasma levels.” Cancer Res 49, no. 20 (October 15, 1989): 5761–65.Link to Item
-
Kroll, S. S., R. Pollock, J. M. Jessup, and D. Ota. “Transpelvic rectus abdominis flap reconstruction of defects following abdominal-perineal resection.” Am Surg 55, no. 10 (October 1989): 632–37.Link to Item
-
Grossie, V. B., D. M. Ota, J. A. Ajani, T. H. Chang, D. Patenia, and K. Nishioka. “Reduction of difluoromethylornithine-induced thrombocytopenia in rats with ornithine while maintaining antitumor activity.” Cancer Res 49, no. 15 (August 1, 1989): 4159–62.Link to Item
-
Yamori, T., D. M. Ota, K. R. Cleary, S. Hoff, L. G. Hager, and T. Irimura. “Monoclonal antibody against human colonic sulfomucin: immunochemical detection of its binding sites in colonic mucosa, colorectal primary carcinoma, and metastases.” Cancer Res 49, no. 4 (February 15, 1989): 887–94.Link to Item
-
Jackson, G. L., S. Pathak, L. A. Jones, V. Vogel, K. I. Kemp, D. M. Ota, P. Kulkarni, S. Vernon, P. Conoley, and V. Hopwood. “Breast cancer screening-individualized risk assessment and application of new research technology: non-protein bound estradiol and chromosome analysis.” Prog Clin Biol Res 293 (1989): 271–78.Link to Item
-
Rich, T. A., L. L. Hughes, J. M. Jessup, D. M. Ota, F. C. Ames, D. C. Hohn, R. G. Martin, J. A. Ajani, and J. L. Abbruzzese. “Conservative management of anal and low rectal cancers with combined modality therapy.” Cancer Bulletin 41, no. 2 (January 1, 1989): 71–74.
-
Grossie, V. B., K. Nishioka, T. H. Chang, D. Patenia, M. M. Benitez, J. A. Ajani, and D. M. Ota. “Differential effects of parenteral nutrition on tumor growth and erythrocyte polyamine levels in the rat.” Jpen J Parenter Enteral Nutr 13, no. 6 (1989): 590–95. https://doi.org/10.1177/0148607189013006590.Full Text Link to Item
-
McCready, D. R., D. M. Ota, T. A. Rich, D. Thielvoldt, and J. M. Jessup. “Prospective phase I trial of conservative management of low rectal lesions.” Arch Surg 124, no. 1 (January 1989): 67–70. https://doi.org/10.1001/archsurg.1989.01410010077016.Full Text Link to Item
-
Nishioka, K., V. B. Grossie, J. A. Ajani, D. Patenia, T. H. Chang, and D. M. Ota. “Polyamine-directed preferential nutritional repletion of normal tissues in tumor-bearing hosts.” Int J Cancer 42, no. 5 (November 15, 1988): 744–47. https://doi.org/10.1002/ijc.2910420520.Full Text Link to Item
-
Irimura, T., D. A. Carlson, J. Price, T. Yamori, R. Giavazzi, D. M. Ota, and K. R. Cleary. “Differential expression of a sialoglycoprotein with an approximate molecular weight of 900,000 on metastatic human colon carcinoma cells growing in culture and in tumor tissues.” Cancer Res 48, no. 9 (May 1, 1988): 2353–60.Link to Item
-
Irimura, T., D. A. Carlson, and D. M. Ota. “Electrophoretic analysis of four high molecular weight sialoglycoproteins produced by metastatic human colon carcinoma cells.” J Cell Biochem 37, no. 1 (May 1988): 1–9. https://doi.org/10.1002/jcb.240370102.Full Text Link to Item
-
Yamori, T., D. M. Ota, K. R. Cleary, and T. Irimura. “Increased content of chondroitin sulfate proteoglycan in human colorectal carcinoma metastases compared with the primary tumor as determined by an anti-chondroitin-sulfate monoclonal antibody.” J Cell Biochem 36, no. 4 (April 1988): 405–16. https://doi.org/10.1002/jcb.240360409.Full Text Link to Item
-
Irimura, T., M. Nakajima, T. Yamori, D. M. Ota, K. F. Cleary, and G. L. Nicolson. “Glycoconjugates and tumor metastasis.” Adv Exp Med Biol 228 (1988): 677–704. https://doi.org/10.1007/978-1-4613-1663-3_27.Full Text Link to Item
-
Grossie, V. B., D. M. Ota, J. A. Ajani, T. H. Chang, D. Patenia, and K. Nishioka. “Influence of total parenteral nutrition on tumor growth and polyamine biosynthesis of fibrosarcoma-bearing rats after induced cachexia.” Jpen J Parenter Enteral Nutr 12, no. 5 (1988): 441–44. https://doi.org/10.1177/0148607188012005441.Full Text Link to Item
-
Jones, L. A., D. M. Ota, G. A. Jackson, P. M. Jackson, K. Kemp, D. E. Anderson, S. K. McCamant, and D. H. Bauman. “Bioavailability of estradiol as a marker for breast cancer risk assessment.” Cancer Res 47, no. 19 (October 1, 1987): 5224–29.Link to Item
-
Dimery, I. W., K. Nishioka, V. B. Grossie, D. M. Ota, S. P. Schantz, R. Byers, K. T. Robbins, and W. K. Hong. “Polyamine metabolism in carcinoma of the oral cavity compared with adjacent and normal oral mucosa.” Am J Surg 154, no. 4 (October 1987): 429–33. https://doi.org/10.1016/0002-9610(89)90018-4.Full Text Link to Item
-
Irimura, T., T. Yamori, S. C. Bennett, D. M. Ota, and K. R. Cleary. “The relationship of collagenolytic activity to stage of human colorectal carcinoma.” Int J Cancer 40, no. 1 (July 15, 1987): 24–31. https://doi.org/10.1002/ijc.2910400106.Full Text Link to Item
-
Yamori, T., H. Kimura, K. Stewart, D. M. Ota, K. R. Cleary, and T. Irimura. “Differential production of high molecular weight sulfated glycoproteins in normal colonic mucosa, primary colon carcinoma, and metastases.” Cancer Res 47, no. 10 (May 15, 1987): 2741–47.Link to Item
-
Grossie, V. B., D. M. Ota, J. A. Ajani, and K. Nishioka. “Effect of intravenous alpha-difluoromethylornithine on the polyamine levels of normal tissue and a transplantable fibrosarcoma.” Cancer Res 47, no. 7 (April 1, 1987): 1836–40.Link to Item
-
Irimura, T., D. M. Ota, and K. R. Cleary. “Ulex europeus agglutinin I-reactive high molecular weight glycoproteins of adenocarcinoma of distal colon and rectum and their possible relationship with metastatic potential.” Cancer Res 47, no. 3 (February 1, 1987): 881–89.Link to Item
-
Jones, L. A., D. M. Ota, G. A. Jackson, P. M. Jackson, K. Kemp, D. E. Anderson, S. K. McCamant, and D. H. Bauman. “Bioavailability of Estradiol as a Marker for Breast Cancer Risk Assessment.” Cancer Research 47, no. 19 (January 1, 1987): 5092–5140.
-
Ota, D. M., V. B. Grossie, J. A. Ajani, L. C. Stephens, and K. Nishioka. “Red blood cell polyamine levels and host toxicity during continuous alpha-difluoromethylornithine infusion.” Int J Cancer 38, no. 2 (August 15, 1986): 245–49. https://doi.org/10.1002/ijc.2910380215.Full Text Link to Item
-
Grossie, V. B., K. Nishioka, D. M. Ota, and R. G. Martin. “Relationship of erythrocyte polyamine levels and growth rate of transplantable tumors in rats.” Cancer Res 46, no. 7 (July 1986): 3464–68.Link to Item
-
Ota, D. M., G. Kleman, and K. Diamond. “Practical considerations in the nutritional management of the cancer patient.” Curr Probl Cancer 10, no. 7 (July 1986): 345–98. https://doi.org/10.1016/s0147-0272(86)80013-7.Full Text Link to Item
-
Ota, D. M., K. Nishioka, B. Grossie, and D. Dixon. “Erythrocyte polyamine levels during intravenous feeding of patients with colorectal carcinoma.” Eur J Cancer Clin Oncol 22, no. 7 (July 1986): 837–42. https://doi.org/10.1016/0277-5379(86)90371-8.Full Text Link to Item
-
Ota, D. M., L. A. Jones, G. L. Jackson, P. M. Jackson, K. Kemp, and D. Bauman. “Obesity, non-protein-bound estradiol levels, and distribution of estradiol in the sera of breast cancer patients.” Cancer 57, no. 3 (February 1, 1986): 558–62. https://doi.org/10.1002/1097-0142(19860201)57:3<558::aid-cncr2820570326>3.0.co;2-1.Full Text Link to Item
-
Grossie, V. B., K. Nishioka, and D. M. Ota. “Ornithine decarboxylase activity of normal tissue from tumor-bearing rats.” Journal of Nutrition Growth and Cancer 3, no. 1 (January 1, 1986): 41–46.
-
Jackson, P. M., G. L. Jackson, K. Kemp, D. H. Bauman, D. M. Ota, and L. A. Jones. “Development of a breast cancer screening & research program.” Prog Clin Biol Res 216 (1986): 71–78.Link to Item
-
Jessup, J. M., C. M. McBride, F. C. Ames, L. Guarda, D. M. Ota, M. M. Romsdahl, and R. G. Martin. “Active specific immunotherapy of Dukes B2 and C colorectal carcinoma: comparison of two doses of the vaccine.” Cancer Immunol Immunother 21, no. 3 (1986): 233–39. https://doi.org/10.1007/BF00199367.Full Text Link to Item
-
Ota, D. M., P. Frasier, J. Guevara, and M. Foulkes. “Plasma proteins as indices of response to nutritional therapy in cancer patients.” J Surg Oncol 29, no. 3 (July 1985): 160–65. https://doi.org/10.1002/jso.2930290306.Full Text Link to Item
-
Harris, W. B., V. B. Grossie, D. M. Ota, K. Nishioka, J. A. Ajani, T. Chang, and D. Patenia. “Effect of difluoromethylornithine on host and tumor polyamine metabolism during total parenteral nutrition.” J Surg Res 38, no. 6 (June 1985): 592–98. https://doi.org/10.1016/0022-4804(85)90080-0.Full Text Link to Item
-
Ota, D. M., and B. Drewinko. “Growth kinetics of human colorectal carcinoma.” Cancer Res 45, no. 5 (May 1985): 2128–31.Link to Item
-
Miller, W., D. Ota, G. Giacco, V. Guinee, T. Irimura, G. Nicolson, and K. Cleary. “Absence of a relationship of size of primary colon carcinoma with metastasis and survival.” Clin Exp Metastasis 3, no. 3 (1985): 189–96. https://doi.org/10.1007/BF01786762.Full Text Link to Item
-
Ota, D. M., J. M. Jessup, G. F. Babcock, L. Kirschbaum, C. F. Mountain, M. J. McMurtrey, and E. M. Copeland. “Immune function during intravenous administration of a soybean oil emulsion.” Jpen J Parenter Enteral Nutr 9, no. 1 (1985): 23–27. https://doi.org/10.1177/014860718500900123.Full Text Link to Item
-
Ota, D., L. Alvarez, B. Lichtiger, G. Giacco, and V. Guinee. “Perioperative blood transfusion in patients with colon carcinoma.” Transfusion 25, no. 4 (1985): 392–94. https://doi.org/10.1046/j.1537-2995.1985.25485273825.x.Full Text Link to Item
-
Pollock, R. E., F. C. Ames, D. M. Ota, and P. Mansell. “A surgical oncology perspective on AIDS.” Semin Surg Oncol 1, no. 3 (1985): 153–60. https://doi.org/10.1002/ssu.2980010306.Full Text Link to Item
-
Ota, D. M., K. Nishioka, M. Foulkes, and V. B. Grossie. “Nutritional parameters affecting erythrocyte polyamine levels in cancer patients.” J Clin Oncol 2, no. 10 (October 1984): 1157–64. https://doi.org/10.1200/JCO.1984.2.10.1157.Full Text Link to Item
-
Copeland, E. M., D. M. Ota, and L. C. Cox. “Hyperalimentation and oncologic management: update.” Compr Ther 9, no. 11 (November 1983): 64–69.Link to Item
-
Floyd, C. M., D. Ota, J. Corriere, S. J. Dudrick, and E. M. Copeland. “Effect of serum source on protein-free diet lymphocyte blastogenesis.” J Surg Res 35, no. 3 (September 1983): 243–48. https://doi.org/10.1016/s0022-4804(83)80010-9.Full Text Link to Item
-
Grossie, V. B., C. E. Castro, and D. M. Ota. “Modification of polycarbonate cages for individual housing of mice.” Lab Anim Sci 33, no. 4 (August 1983): 365.Link to Item
-
OTA, D. M., and E. M. COPELAND. “GASTROINTESTINAL CANCER .5. NUTRITIONAL THERAPY IN CANCER-PATIENTS.” Practical Gastroenterology 6, no. 2 (January 1, 1982): 9–12.Link to Item
-
Floyd, C., D. Ota, J. N. Corriere, S. J. Dudrick, and E. M. Copeland. “Effect of protein depletion on serum factors for lymphocyte transformation.” Surg Forum 30 (1979): 57–60.Link to Item
-
Ota, D. M., E. M. Copeland, J. N. Corriere, and S. J. Dudrick. “The effects of nutrition and treatment of cancer on host immunocompetence.” Surg Gynecol Obstet 148, no. 1 (January 1979): 104–11.Link to Item
-
Dudrick, S. J., E. M. Copeland, J. M. Daly, J. M. Long, J. H. Duke, B. V. MacFadyen, B. J. Rowlands, et al. “A clinical review of nutritional support of the patient.” Jpen J Parenter Enteral Nutr 3, no. 6 (1979): 444–51. https://doi.org/10.1177/014860717900300608.Full Text Link to Item
-
Ota, D. M., A. L. Imbembo, and G. D. Zuidema. “Total parenteral nutrition.” Surgery 83, no. 5 (May 1978): 503–20.Link to Item
-
Ota, D. M., E. M. Copeland, J. N. Corriere, E. R. Richie, K. Jacobson, and S. J. Dudrick. “The effects of a 10% soybean oil emulsion on lymphocyte transformation.” Jpen J Parenter Enteral Nutr 2, no. 2 (May 1978): 112–15. https://doi.org/10.1177/014860717800200205.Full Text Link to Item
-
Ota, D. M., E. M. Copeland, H. W. Strobel, J. Daly, E. T. Gum, E. Guinn, and S. J. Dudrick. “The effect of protein nutrition on host and tumor metabolism.” J Surg Res 22, no. 3 (March 1977): 181–88. https://doi.org/10.1016/0022-4804(77)90132-9.Full Text Link to Item
-
Ota, D. M., E. M. Copeland, J. N. Corriere, K. A. Jacobson, and S. J. Dudrick. “Effects of protein nutrition on lymphocyte transformation.” Surg Forum 28 (1977): 65–66.Link to Item
-
Ota, D. M. “The use of histidase for the study of amniotic cell origin and histidinemia.” Am J Obstet Gynecol 117, no. 4 (October 15, 1973): 567–71. https://doi.org/10.1016/0002-9378(73)90123-3.Full Text Link to Item
-
-
Other Articles
-
Ota, David M., Heidi Nelson, and Armando Giuliano. “Node biopsy vs. full lymph node dissection for breast cancer.” Bull Am Coll Surg, October 2010.Link to Item
-
Ota, David M., and Heidi Nelson. “Changing multidisciplinary cancer treatment through ACOSOG trials.” Bull Am Coll Surg, April 2010.Link to Item
-
Wilke, Lee Gravatt, Heidi Nelson, and David M. Ota. “Promoting patient safety through peer review.” Bull Am Coll Surg, March 2010.Link to Item
-
Nelson, Heidi, and David Ota. “Promoting patient safety.” Bull Am Coll Surg, December 2009.Link to Item
-
You, Y Nancy, David Ota, and Heidi Nelson. “The American College of Surgeons Oncology Group.” Surgery, June 2009. https://doi.org/10.1016/j.surg.2009.03.009.Full Text Link to Item
-
Lind, D. S., N. P. Schaub, M. Hawkins, K. W. Sharp, D. Ota, and K. Bland. “Discussion.” American Surgeon, August 1, 2008.
-
Ota, David, and Heidi Nelson. “A phase II trial for minimally invasive esophagectomy.” Bull Am Coll Surg, February 2008.Link to Item
-
Ota, David M., Heidi Nelson, and Heidi ACOSOG Group Co-Chairs. “Local excision of rectal cancer revisited: ACOSOG protocol Z6041.” Ann Surg Oncol, February 2007. https://doi.org/10.1245/s10434-006-9213-7.Full Text Link to Item
-
Ota, David, and Heidi Nelson. “The surgeon and adjuvant therapy for stage II colon cancer.” Ann Surg Oncol, February 2007. https://doi.org/10.1245/s10434-006-9161-2.Full Text Link to Item
-
Ota, D. M., and H. Nelson. “Coin of the realm.” Annals of Surgical Oncology, July 1, 2006. https://doi.org/10.1245/ASO.2006.04.0236.Full Text
-
Ota, D. M. “A pilot study of preoperative chemoradiation for gastric cancer.” Ann Surg Oncol, July 2001. https://doi.org/10.1007/s10434-001-0482-x.Full Text Link to Item
-
Ota, D. M. “The Wexner/Hwang article reviewed.” Oncology, December 1, 2000.
-
Pestieau, S. R., and P. H. Sugarbaker. “Treatment of primary colon cancer with peritoneal carcinomatosis: comparison of concomitant vs. delayed management.” Dis Colon Rectum, October 2000. https://doi.org/10.1007/BF02236627.Full Text Link to Item
-
Ota, D. M. “Is intraoperative lymph node mapping and sentinel lymph node biopsy for colorectal carcinoma necessary?” Ann Surg Oncol, March 2000. https://doi.org/10.1007/s10434-000-0082-1.Full Text Link to Item
-
Boddie, A. W., A. W. Mahvi, D. M. Ota, R. A. Prinz, and J. Pickleman. “Perivascular and intralesional tissue necrosis after hepatic cryoablation: Results in a porcine model - Discussion.” Surgery. MOSBY-YEAR BOOK INC, October 1, 1997.Link to Item
-
Dawes, L. G., L. G. Liu, G. M. Fried, and D. M. Ota. “Carcinoma involving the gallbladder in elderly patients presenting with acute cholecystitis - Discussion.” Surgery. MOSBY-YEAR BOOK INC, October 1, 1997.Link to Item
-
DeBord, J. R., R. B. Arenas, B. A. Harms, and D. M. Ota. “Incidence and therapeutic implications of synchronous colonic pathology in colorectal adenocarcinoma - Discussion.” Surgery. MOSBY-YEAR BOOK INC, October 1, 1997.Link to Item
-
Harms, B. A., S. B. Archer, D. M. Ota, T. A. Stellato, R. M. Zollinger, N. C. Estes, and A. Senagore. “Implementation of a clinical pathway decreases length of stay and hospital charges for patients undergoing total colectomy and ileal pouch anal anastomosis - Discussion.” Surgery. MOSBY-YEAR BOOK INC, October 1, 1997.Link to Item
-
Sarr, M. G., P. Iannoli, J. S. Thompson, and D. M. Ota. “Epidermal growth factor and human growth hormone accelerate adaptation after massive enterectomy in an additive, nutrient-dependent, and site-specific fashion - Discussion.” Surgery. MOSBY-YEAR BOOK INC, October 1, 1997.Link to Item
-
Ota, D. M. “Preoperative radiotherapy for rectal cancer: benefits and controversies.” Ann Surg Oncol, September 1996. https://doi.org/10.1007/BF02305757.Full Text Link to Item
-
Ota, D. M. “Laparoscopic colectomy for cancer: a favorable opinion.” Ann Surg Oncol, January 1995. https://doi.org/10.1007/BF02303695.Full Text Link to Item
-
Ota, D. M., and D. B. Evans. “Feeding jejunostomy techniques.” Surgery, May 1993.Link to Item
-
-
Conference Papers
-
Ellis, Matthew James, Li Ding, Dong Shen, Jingqin Luo, Vera J. Suman, Reece J. Goiffon, John W. Wallis, et al. “Whole genome sequencing to characterize luminal-type breast cancer.” In Journal of Clinical Oncology, Vol. 30. AMER SOC CLINICAL ONCOLOGY, 2012.Link to Item
-
Chan, E., Q. Shi, J. Garcia-Aguilar, B. G. Wolff, C. S. Johnson, B. Sanders, X. Carrero, M. C. Posner, D. M. Ota, and C. R. Thomas. “Chemoradiation (CRT) Safety Analysis of ACOSOG Z6041: A Phase II Trial of Neoadjuvant (NEO) CRT followed by Local Excision (LE) in uT2 Rectal Cancer (RC).” In International Journal of Radiation Oncology*Biology*Physics, 78:S53–54. Elsevier BV, 2010. https://doi.org/10.1016/j.ijrobp.2010.07.159.Full Text
-
Brenner, B. M., W. Vandewalle, R. A. Komorowski, and D. M. Ota. “The onset of genomic instability in sporadic colorectal polyps.” In Annals of Surgical Oncology, 11:S85–86. Springer Science and Business Media LLC, 2004. https://doi.org/10.1007/bf02524074.Full Text
-
Jacobs, L. K., B. W. Kuvshinoff, K. M. Lin, M. P. Watson, and D. M. Ota. “Preoperative 5-FU and radiation therapy increases sphincter preservation rates and improves R0 resection rates for rectal cancer.” In Annals of Surgical Oncology, 9:S73–S73. LIPPINCOTT WILLIAMS & WILKINS, 2002.Link to Item
-
Lin, K. M., J. Greer, C. Ridpath, M. Miller, L. Jacobs, B. Kuvshinoff, and D. M. Ota. “Incidence of invasive breast cancer following initial diagnosis of nonpalpable ductal carcinoma in-situ by stereotactic core needle biopsy.” In Annals of Surgical Oncology, 9:S57–S57. LIPPINCOTT WILLIAMS & WILKINS, 2002.Link to Item
-
Miller, M. L., K. Lin, L. Jacobs, B. Kuvshinoff, T. Loy, F. Rodriguez, M. Watson, and D. M. Ota. “Pathologic features affecting detection of metastasis in breast cancer sentinel lymph nodes during intraoperative frozen section analysis.” In Annals of Surgical Oncology, 9:S60–S60. LIPPINCOTT WILLIAMS & WILKINS, 2002.Link to Item
-
Kuvshinoff, B. W., I. Magfoor, B. Miedema, J. Wilkes, S. Westgate, and D. M. Ota. “Preoperative chemoradiotherapy permits <1 CM distal margin and sphincter preservation for distal rectal cancer.” In Gastroenterology, 114:A1403–A1403. Elsevier BV, 1998. https://doi.org/10.1016/s0016-5085(98)85703-x.Full Text
-
Feig, B. W., C. A. Staley, P. F. Mansfield, L. M. Ellis, J. M. Skibber, A. Madary, and D. M. Ota. “The efficacy of laparoscopic colon resection for cancer.” In Gastroenterology, 110:A1383–A1383. W B SAUNDERS CO-ELSEVIER INC, 1996.Link to Item
-
FEIG, B. W., D. H. BERGER, J. F. DUPUIS, T. B. DOUGHERTY, D. A. JOHNSTON, R. J. GROSS, and D. M. OTA. “HEMODYNAMIC-EFFECTS OF CO2 ABDOMINAL INSUFFLATION (CAI) DURING LAPAROSCOPY IN HIGH-RISK PATIENTS.” In Anesthesia and Analgesia, 78:U68–U68. WILLIAMS & WILKINS, 1994.Link to Item
-
FEIG, B. W., D. H. BERGER, T. B. DOUGHERTY, J. F. DUPUIS, D. A. JOHNSTON, R. J. GROSS, and D. M. OTA. “PULMONARY EFFECTS OF CO2 ABDOMINAL INSUFFLATION (CAI) DURING LAPAROSCOPY IN HIGH-RISK PATIENTS.” In Anesthesia and Analgesia, 78:U67–U67. WILLIAMS & WILKINS, 1994.Link to Item
-
Weinstein, Geoffrey D., Tyvin A. Rich, Charles R. Shumate, John M. Skibber, Jaffer A. Ajani, and David M. Ota. “Preoperative chemoradiation and complete surgical excision with or without intraoperative electron beam boost (EB-IORT) for advanced primary rectal cancer.” In International Journal of Radiation Oncology*Biology*Physics, 27:277–277. Elsevier BV, 1993. https://doi.org/10.1016/0360-3016(93)90873-t.Full Text
-
NISHIOKA, K., V. B. GROSSIE, T. H. CHANG, J. A. AJANI, and D. M. OTA. “COLORECTAL ORNITHINE DECARBOXYLASE ACTIVITY IN HUMAN MUCOSA AND TUMORS - ELEVATION OF ENZYMATIC-ACTIVITY IN DISTAL MUCOSA - POSTER.” In Polyamines in the Gastrointestinal Tract, edited by R. H. DOWLING, U. R. FOLSCH, and C. LOSER, 62:522–522. KLUWER ACADEMIC PUBL, 1992.Link to Item
-
GROSSIE, V. B., K. NISHIOKA, R. MEDLEY, J. A. AJANI, and D. M. OTA. “ROLE OF ARGININE IN TOTAL PARENTERAL-NUTRITION (TPN)-ENHANCED TUMOR-GROWTH IN THE RAT.” In Faseb Journal, 2:A860–A860. FEDERATION AMER SOC EXP BIOL, 1988.Link to Item
-
GROSSIE, V. B., D. M. OTA, J. A. AJANI, and K. NISHIOKA. “MODULATION OF DIFLUOROMETHYLORNITHINE TOXICITY BY CONCOMITANT ORNITHINE TREATMENT IN TUMOR-BEARING RATS.” In Proceedings of the American Association for Cancer Research, 29:346–346. AMER ASSOC CANCER RESEARCH, 1988.Link to Item
-
IRIMURA, T., D. A. CARLSON, M. YAGITA, E. A. GRIMM, and D. M. OTA. “INCREASED EXPRESSION OF COLON-CARCINOMA SIALOMUCIN INDUCED BY NORMAL TISSUE FACTORS AND ITS ASSOCIATION WITH IMMUNE EFFECTOR RESISTANCE.” In Proceedings of the American Association for Cancer Research, 29:400–400. AMER ASSOC CANCER RESEARCH, 1988.Link to Item
-
YAMORI, T., T. IRIMURA, D. M. OTA, K. R. CLEARY, and S. HOFF. “DETECTION OF SULFOMUCIN EXPRESSION IN COLONIC MUCOSA, PRIMARY COLON-CARCINOMA AND METASTASES USING A SPECIFIC MONOCLONAL-ANTIBODY (91.9H).” In Proceedings of the American Association for Cancer Research, 29:63–63. AMER ASSOC CANCER RESEARCH, 1988.Link to Item
-
IRIMURA, T., D. A. CARLSON, M. YAGITA, E. A. GRIMM, and D. M. OTA. “COLON-CARCINOMA SIALOMUCIN PRODUCTION STIMULATED BY MUCOMODULIN AND ASSOCIATION WITH INCREASED IMMUNE EFFECTOR RESISTANCE.” In Glycoconjugate Journal, 5:300–300. CHAPMAN HALL LTD, 1988.Link to Item
-
MATSUSHITA, Y., S. HOFF, D. M. OTA, K. R. CLEARY, and T. IRIMURA. “SIALYL DIMERIC-LEWIS-X ANTIGEN EXPRESSED ON MUCIN-LIKE GLYCOPROTEINS IN COLON CANCER METASTASIS.” In Glycoconjugate Journal, 5:322–322. CHAPMAN HALL LTD, 1988.Link to Item
-
YAMORI, T., L. HAGER, H. KIMURA, D. M. OTA, K. R. CLEARY, and T. IRIMURA. “HUMAN COLONIC SULFOMUCIN AND AN ANTI-SULFOMUCIN MONOCLONAL-ANTIBODY.” In Glycoconjugate Journal, 5:322–322. CHAPMAN HALL LTD, 1988.Link to Item
-
GROSSIE, V. B., D. M. OTA, J. A. AJANI, and K. NISHIOKA. “DIFFERENTIAL EFFECT OF DIFLUOROMETHYLORNITHINE (DFMO) ON HEPATIC AND TUMOR POLYAMINE METABOLISM IN SARCOMA-BEARING RATS.” In Proceedings of the American Association for Cancer Research, 28:319–319. AMER ASSOC CANCER RESEARCH, 1987.Link to Item
-
IRIMURA, T., J. E. HESTER, T. YAMORI, P. N. BELLONI, I. J. FIDLER, D. M. OTA, and G. L. NICOLSON. “ADHESIVE PROPERTIES OF HUMAN-COLON CARCINOMA-CELLS ESTABLISHED FROM PRIMARY TUMOR AND METASTASES.” In Proceedings of the American Association for Cancer Research, 28:73–73. AMER ASSOC CANCER RESEARCH, 1987.Link to Item
-
NISHIOKA, K., V. B. GROSSIE, D. M. OTA, and J. A. AJANI. “POLYAMINE DIRECTED PREFERENTIAL NUTRITIONAL REPLETION OF NORMAL-TISSUES IN TUMOR-BEARING HOSTS.” In Proceedings of the American Association for Cancer Research, 28:317–317. AMER ASSOC CANCER RESEARCH, 1987.Link to Item
-
YAMORI, T., H. KIMURA, K. STEWART, D. M. OTA, K. R. CLEARY, and T. IRIMURA. “DIFFERENTIAL PRODUCTION OF HIGH-MOLECULAR-WEIGHT SULFATED GLYCOPROTEINS IN NORMAL COLONIC MUCOSA, PRIMARY COLON-CARCINOMA, AND METASTASIS.” In Journal of Cellular Biochemistry, 115–115. WILEY-LISS, 1987.Link to Item
-
GROSSIE, V. B., D. M. OTA, L. C. STEPHENS, J. AJANI, and K. NISHIOKA. “ANTITUMOR-ACTIVITY AND HOST TOXICITY OF CONTINUOUS INTRAVENOUS (IV) ALPHA-DIFLUOROMETHYLORNITHINE (DFMO).” In Proceedings of the American Association for Cancer Research, 27:292–292. AMER ASSOC CANCER RESEARCH, 1986.Link to Item
-
IRIMURA, T., S. C. BENNETT, T. YAMORI, D. M. OTA, and K. R. CLEARY. “COLLAGENOLYTIC ACTIVITIES OF HUMAN COLORECTAL-CARCINOMA AT DIFFERENT STAGES.” In Proceedings of the American Association for Cancer Research, 27:58–58. AMER ASSOC CANCER RESEARCH, 1986.Link to Item
-
IRIMURA, T., T. YAMORI, K. STEWERT, S. C. BENNETT, D. M. OTA, K. R. CLEARY, and I. J. FIDLER. “CELL-SURFACE GLYCOCONJUGATES OF HUMAN COLORECTAL-CARCINOMA WITH DIFFERENT METASTATIC POTENTIALS.” In Federation Proceedings, 45:686–686. FEDERATION AMER SOC EXP BIOL, 1986.Link to Item
-
YAMORI, T., T. IRIMURA, D. M. OTA, K. R. CLEARY, R. GIAVAZZI, and I. J. FIDLER. “SULFATED GLYCOCONJUGATES PRODUCED BY HUMAN-COLON CARCINOMA CELL-LINES WITH DIFFERENT METASTATIC POTENTIALS.” In Proceedings of the American Association for Cancer Research, 27:63–63. AMER ASSOC CANCER RESEARCH, 1986.Link to Item
-
Harris, W., D. Ota, and B. Grossie. “Monitoring difluoromethyl ornithine(DFMO) inhibition of tumor polyamine(PA) synthesis.” In Proceedings of the American Association for Cancer Research, Vol. VOL. 26, 1985.
-
IRIMURA, T., D. M. OTA, K. R. CLEARY, and G. L. NICOLSON. “GLYCOPROTEIN ANALYSIS OF HUMAN RECTUM AND SIGMOID COLON CARCINOMAS AT VARIOUS STAGES OF METASTASES USING LECTINS.” In Proceedings of the American Association for Cancer Research, 26:49–49. AMER ASSOC CANCER RESEARCH, 1985.Link to Item
-
Irimura, T., D. M. Ota, K. R. Cleary, and G. L. Nicolson. “Glycoprotein analysis of human rectum and Sigmoid colon carcinomas at various stages of metastases using lectins.” In Proceedings of the American Association for Cancer Research, Vol. VOL. 26, 1985.
-
JONES, L. A., D. M. OTA, D. E. ANDERSON, G. L. JACKSON, P. M. JACKSON, K. KEMP, and D. H. BAUMAN. “PERCENT DISTRIBUTION OF ESTRADIOL (E2) IN SERA OF WOMEN WITH BREAST-CANCER (BCA) AND DISEASE-FREE WOMEN WITH (FHCA) AND WITHOUT (NOFHCA) A FAMILY HISTORY OF BREAST-CANCER.” In Proceedings of the American Association for Cancer Research, 26:197–197. AMER ASSOC CANCER RESEARCH, 1985.Link to Item
-
JONES, L. A., D. M. OTA, G. A. JACKSON, K. KEMP, and D. H. BAUMAN. “PERCENT-NON-PROTEIN BOUND (NPBE) AND PERCENT-ALBUMIN BOUND (ABE) ESTRADIOL AS A POSSIBLE BIOMARKER FOR BREAST-CANCER (BCA).” In Breast Cancer Research and Treatment, 6:180–180. KLUWER ACADEMIC PUBL, 1985.Link to Item
-
Jones, L. A., D. M. Ota, and D. E. Anderson. “Distribution of estradiol (E2) in sera of women with breast cancer (BCa) and disease-free women with (FHCa) and without (NoFHCa). A family history of breast cancer.” In Proceedings of the American Association for Cancer Research, Vol. VOL. 26, 1985.
-
GROSSIE, V. B., K. NISHIOKA, and D. M. OTA. “NUTRITIONAL-STATUS AND ERYTHROCYTE (RBC) POLYAMINES (PA) LEVELS IN FIBRO-SARCOMA BEARING RATS.” In Proceedings of the American Association for Cancer Research, 25:51–51. AMER ASSOC CANCER RESEARCH, 1984.Link to Item
-
OTA, D. M., J. M. JESSUP, G. F. BABCOCK, L. KIRSCHBAUM, C. F. MOUNTAIN, M. J. MCMURTREY, and E. M. COPELAND. “IMMUNE FUNCTION DURING SOYBEAN OIL EMULSION INFUSION.” In Journal of Parenteral and Enteral Nutrition, 8:84–84. AMER SOC PARENTERAL & ENTERAL NUTRITION, 1984.Link to Item
-
GROSSIE, V. B., D. M. OTA, R. G. SMITH, and T. L. LOO. “NUTRITIONAL-STATUS AND ANTI-TUMOR ACTIVITY OF CYCLOPHOSPHAMIDE (CP) AGAINST L1210 LEUKEMIA.” In Proceedings of the American Association for Cancer Research, 24:307–307. AMER ASSOC CANCER RESEARCH, 1983.Link to Item
-
DUDRICK, S. J., B. J. ROWLANDS, A. M. SPEIR, D. M. OTA, A. C. HENRY, D. M. ENGLERT, and C. W. COLEMAN. “INTRAVENOUS HYPERALIMENTATION (IVH) AS THE SOLE TREATMENT FOR ANEMIA AND ULCERATIVE-COLITIS (UC) IN 2 JEHOVAHS-WITNESSES.” In Federation Proceedings, 39:1114–1114. FEDERATION AMER SOC EXP BIOL, 1980.Link to Item
-
Ota, D. M., E. M. Copeland, and J. N. Corriere. “Effects of intralipid on lymphocyte transformation.” In Federation Proceedings, Vol. 36, 1977.
-
OTA, D. M., E. M. COPELAND, J. N. CORRIERE, E. R. RICHIE, K. A. JACOBSON, and S. J. DUDRICK. “EFFECTS OF INTRALIPID ON LYMPHOCYTE-TRANSFORMATION.” In Federation Proceedings, 36:1218–1218, 1977.Link to Item
-
-
Some information on this profile has been compiled automatically from Duke databases and external sources. (Our About page explains how this works.) If you see a problem with the information, please write to Scholars@Duke and let us know. We will reply promptly.